v3.26.3
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2026
Fair Value Disclosures [Abstract]  
Schedule of Valuation of the Company's Investments and Financial Instruments that are Measured at Fair Value on a Recurring Basis
The following table summarizes the valuation of the Company’s financial assets and liabilities that are measured at fair value on a recurring basis:

September 30, 2026December 31, 2025
Fair value measurement categoryFair value measurement category
(In thousands)TotalLevel 1Level 2Level 3TotalLevel 1Level 2Level 3
Assets:
Money market funds$80,557 $80,557 $— $— $38,110 $38,110 $— $— 
Commercial paper (a)
3,989 — 3,989 — 7,111 — 7,111 — 
Corporate notes88,275 — 88,275 — 83,034 — 83,034 — 
U.S. government agency bonds9,847 — 9,847 — 10,651 — 10,651 — 
U.S. government securities (a)
42,397 — 42,397 — 47,766 — 47,766 — 
$225,065 $80,557 $144,508 $— $186,672 $38,110 $148,562 $— 
Liabilities:
Deferred compensation plan liabilities$1,483 $— $1,483 $— $1,422 $— $1,422 $— 
Total liabilities$1,483 $— $1,483 $— $1,422 $— $1,422 $— 

(a) Approximately $42.4 million of U.S. government securities had an original maturity of 90 days or less and were recorded as a cash equivalent as of September 30, 2026. Approximately $47.8 million of U.S. government securities and $2.0 million of commercial paper had an original maturity of 90 days or less and were recorded as a cash equivalent as of December 31, 2025.